EXACT SCIENCES CORPORATION

Business Segments Exact Sciences Corporation

Equities

EXAS

US30063P1057

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-13 pm EDT			5-day change	1st Jan Change
53.52 ^USD	-0.91%		-1.58%	-4.75%

Jun. 04	Exact Sciences Corporation, Q1 2025 Earnings Call, May 01, 2025
Jun. 03	Exact Sciences Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 08:40 AM

Sales 2024 by Business Segment

See more © MarketScreener.com

Sales 2024 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Life Sciences Tools and Services
Biotechnology (Startups)						1.49B	1.77B	2.08B	2.5B	2.76B
Total Assets						4.93B	6.68B	6.23B	6.47B	5.93B
Interest Expense						-95.98M	-18.61M	-19.63M	-19.45M	-27.02M
Income Tax Expense						-8.57M	-247M	-9.06M	2.4M	-7.3M
CAPEX						-64.35M	-136M	-214M	-124M	-136M
EBT						-857M	-843M	-633M	-202M	-1.04B
Gross Profit						-	-	-	-	1.92B
D&A						163M	180M	198M	207M	215M
Operating Income						-768M	-856M	-594M	-215M	-1.05B
Net Income						-849M	-596M	-624M	-204M	-1.03B

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
United States						1.41B	1.66B	1.97B	2.35B	2.57B
Total Assets						-	-	6.23B	6.47B	5.93B
Interest Expense						-	-	-	-	-
Income Tax Expense						-	-	-	-	-
D&A						-	-	-	-	-
CAPEX						-	-	-	-	-
Gross Profit						-	-	-	-	-
Net Income						-	-	-	-	-
EBT						-	-	-	-	-
Operating Income						-	-	-	-	-
Outside of United States						77.48M	110M	118M	153M	189M